Skip to main content
Terug
DHC logo

Diversified Healthcare Trust

Datakwaliteit: 100%
DHC
NASDAQ Real Estate REIT - Healthcare Facilities
€ 6,71
▲ € 0,01 (0,15%)
Marktkapitalisatie: 1,62B
Dagbereik
€ 6,46 € 6,72
52-Weeksbereik
€ 2,00 € 7,66
Volume
1.066.458
50D / 200D Gem.
€ 6,38 / € 4,68
Vorige Slotkoers
€ 6,70

Koershistorie

Financiële Trends

Sectorvergelijking

vs Real Estate sector mediaan (361 peers)

Metriek Aandeel Sector Mediaan
P/E -5,7 11,1
P/B 1,0 0,8
ROE % -15,8 6,1
Net Margin % -18,6 19,9
Rev Growth 5Y % 2,7 7,0
D/E 0,0 0,9

Koersdoel Analisten

Hold
€ 5,00 -25.5%
Forward WPA
-€ 0,54
Omzet Sch.
1,6 B

Winstschattingen

Periode WPA Sch. Omzet Sch. Analisten
FY2027 -€ 0,45
-€ 0,45 – -€ 0,44
1,7 B 1
FY2026 -€ 0,54
-€ 0,54 – -€ 0,54
1,6 B 1

Belangrijkste Punten

Revenue grew 2,68% annually over 5 years — modest growth
Debt/Equity of 0,00 — conservative balance sheet
Negative free cash flow of -19,62M
PEG of 0,18 suggests growth is underpriced
Capital efficient — spends only 0,00% of revenue on capex

Groei

Revenue Growth (5Y)
2,68%
Revenue (1Y)2,84%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-15,78%
ROIC-1,77%
Net Margin-18,59%
Op. Margin-2,55%

Veiligheid

Debt / Equity
0,00
Current RatioN/A
Interest Coverage-0,19

Waardering

P/E Ratio
-5,68
P/B Ratio0,98
EV/EBITDAN/A
Dividend Yield0,01%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 2,84% Revenue Growth (3Y) 4,42%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 2,68% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 1,54B Net Income (TTM) -285,89M
ROE -15,78% ROA -6,56%
Gross Margin -15,95% Operating Margin -2,55%
Net Margin -18,59% Free Cash Flow (TTM) -19,62M
ROIC -1,77% FCF Growth (3Y) N/A
Safety
Debt / Equity 0,00 Current Ratio N/A
Interest Coverage -0,19 Dividend Yield 0,01%
Valuation
P/E Ratio -5,68 P/B Ratio 0,98
P/S Ratio 1,06 PEG Ratio 0,18
EV/EBITDA N/A Dividend Yield 0,01%
Market Cap 1,62B Enterprise Value 1,52B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 1,54B 1,50B 1,41B 1,28B 1,38B
Net Income -285,89M -370,26M -293,57M -15,77M 174,52M
EPS (Diluted) -1,19 -1,55 -1,23 -0,07 0,73
Gross Profit -245,33M 256,38M 225,30M 174,50M 291,40M
Operating Income -39,27M 229,86M 199,17M -91,22M -13,82M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 4,36B 5,14B 5,45B 6,00B 6,62B
Total Liabilities 2,70B 3,18B 3,11B 3,36B 3,96B
Shareholders' Equity 1,67B 1,96B 2,34B 2,64B 2,66B
Total Debt 0,0 2,91B 2,82B 3,08B 3,68B
Cash & Equivalents 105,41M 144,58M 245,94M 658,07M 634,85M
Current Assets 105,41M 430,18M 262,49M 697,40M 1,10B
Current Liabilities 0,0 38,11M 29,94M 734,62M 29,85M